NSPR: Innovative carotid stent technology is set to transform stroke prevention and capture U.S. market share
A novel carotid stent with a 20-micron mesh is driving best-in-class outcomes and rapid adoption in a $1B U.S. market, supported by strong clinical evidence, recent CMS reimbursement, and robust funding. TCAR and CAS market expansion is underway, with FDA approvals and relaunch plans in progress.Ba…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.